kentucky glp-1 stomach paralysis legal team OZEMPIC FEET": As drugs continue to gain popularity for weight loss, a lesser-known side effect is drawing attention from podiatrists: "Ozempic feet." Read the full story in the link in our Weight Loss Drugs Lawsuit |

Are these safe

Obesity in hidradenitis suppurativa: are GLP-1 receptor agonists the new frontier

and acknowledgement that patient equity considerations must be balanced against theoretical safety concerns [48]

As more details become available for the Administrations agreements, we will see how state Medicaid responds. The Department of Health and Human Services referred questions to the White House, which did not respond to requests for comment on states termination of Medicaid coverage for the weight loss drugs

GLP-1 agonists have demonstrated effectiveness in lowering HbA1c levels, promoting weight loss, and reducing cardiovascular risks, making them increasingly attractive treatment options

Patients should be monitored regularly for treatment response, tolerability, and potential complications